John Muscedere1, Marianna Ofner2, Anand Kumar3, Jennifer Long4, Francois Lamontagne5, Deborah Cook6, Allison McGeer7, Clarence Chant8, John Marshall8, Philippe Jouvet9, Robert Fowler4. 1. Department of Medicine, Queen's University, Kingston, ON. Electronic address: muscedej@kgh.kari.net. 2. Public Health Agency of Canada, Ottawa, ON and Winnipeg, MB. 3. Winnipeg Health Sciences Centre and St. Boniface Hospital, University of Manitoba, Winnipeg, MB. 4. Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON. 5. Clinical Research Centre Étienne Le Bel and Department of Medicine, Université de Sherbrooke, Sherbrooke, QC. 6. Faculty of Health Sciences, McMaster University, Hamilton, ON. 7. Mt. Sinai Hospital, University of Toronto, Toronto, ON. 8. St. Michael's Hospital, Toronto, ON. 9. Sainte-Justine Research Center, Université de Montréal, QC, Canada.
Abstract
BACKGROUND: Although secondary infections are recognized as a cause of morbidity and mortality in seasonal influenza, their frequency, characteristics, and associated clinical outcomes in 2009 influenza A(H1N1) (A[H1N1])-related critical illness are unknown. METHODS: In a prospective cohort of adult patients admitted to Canadian ICUs with influenza A(H1N1) infection, the frequency and associated clinical outcomes of prevalent (culture taken within 72 h of ICU admission) and ICU-acquired (culture taken after 72 h from ICU admission) positive bacterial cultures were determined. RESULTS: Among 681 patients, the mean age was 47.9 years (SD, 15.1), APACHE (Acute Physiology and Chronic Health Examination) II score was 21.0 (9.9), and 573 patients (84.0%) were invasively mechanically ventilated. Positive cultures were obtained in 259 patients (38.0%): 77 (29.7%) had prevalent, 115 (44.4%) had ICU-acquired, and 40 (15.4%) had both; culture date was unavailable in 27 (10.4%). The most common bacterial organisms isolated were coagulase-negative staphylococci, Staphylococcus aureus, Pseudomonas species, and Streptococcus pneumoniae. Antibiotics were prescribed in 661 (97.1%), with 3.8 (1.9) prescriptions per patient. Patients with any positive culture had longer days of mechanical ventilation (mean [SD], 15.2 [10.7] vs 10.7 [9.0]; P<.0001), ICU stay (median [interquartile range (IQR)], 18.2 [12.5] days vs 10.8 [9.0] days, P<.0001), and hospitalization (median [IQR], 30.7 [20.7] days vs 19.2 [17.4] days, P<.0001) and a trend toward increased hospital mortality (25.1% vs 19.9%, P=.15). Patients with ICU-acquired positive cultures had worse outcomes compared with those with positive prevalent cultures or who were culture-negative. CONCLUSION: Culture-based evidence of secondary infections commonly complicates A(H1N1)-related critical illness and is associated with worse clinical outcomes despite nearly ubiquitous antibiotic administration.
BACKGROUND: Although secondary infections are recognized as a cause of morbidity and mortality in seasonal influenza, their frequency, characteristics, and associated clinical outcomes in 2009 influenza A(H1N1) (A[H1N1])-related critical illness are unknown. METHODS: In a prospective cohort of adult patients admitted to Canadian ICUs with influenza A(H1N1) infection, the frequency and associated clinical outcomes of prevalent (culture taken within 72 h of ICU admission) and ICU-acquired (culture taken after 72 h from ICU admission) positive bacterial cultures were determined. RESULTS: Among 681 patients, the mean age was 47.9 years (SD, 15.1), APACHE (Acute Physiology and Chronic Health Examination) II score was 21.0 (9.9), and 573 patients (84.0%) were invasively mechanically ventilated. Positive cultures were obtained in 259 patients (38.0%): 77 (29.7%) had prevalent, 115 (44.4%) had ICU-acquired, and 40 (15.4%) had both; culture date was unavailable in 27 (10.4%). The most common bacterial organisms isolated were coagulase-negative staphylococci, Staphylococcus aureus, Pseudomonas species, and Streptococcus pneumoniae. Antibiotics were prescribed in 661 (97.1%), with 3.8 (1.9) prescriptions per patient. Patients with any positive culture had longer days of mechanical ventilation (mean [SD], 15.2 [10.7] vs 10.7 [9.0]; P<.0001), ICU stay (median [interquartile range (IQR)], 18.2 [12.5] days vs 10.8 [9.0] days, P<.0001), and hospitalization (median [IQR], 30.7 [20.7] days vs 19.2 [17.4] days, P<.0001) and a trend toward increased hospital mortality (25.1% vs 19.9%, P=.15). Patients with ICU-acquired positive cultures had worse outcomes compared with those with positive prevalent cultures or who were culture-negative. CONCLUSION: Culture-based evidence of secondary infections commonly complicates A(H1N1)-related critical illness and is associated with worse clinical outcomes despite nearly ubiquitous antibiotic administration.
Authors: Benjamin Lee; Keven M Robinson; Kevin J McHugh; Erich V Scheller; Sivanarayana Mandalapu; Chen Chen; Y Peter Di; Michelle E Clay; Richard I Enelow; Patricia J Dubin; John F Alcorn Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-05-22 Impact factor: 5.464
Authors: Ignacio Martin-Loeches; Marcus J Schultz; Jean-Louis Vincent; Francisco Alvarez-Lerma; Lieuwe D Bos; Jordi Solé-Violán; Antoni Torres; Alejandro Rodriguez Journal: Intensive Care Med Date: 2016-10-05 Impact factor: 17.440
Authors: Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy Journal: Intensive Care Med Date: 2021-10-02 Impact factor: 17.440
Authors: Annabelle M de St Maurice; Brian C Bridges; Peter T Rycus; Christopher J Fonnesbeck; Geoffrey M Fleming; Natasha B Halasa Journal: Pediatr Crit Care Med Date: 2016-09 Impact factor: 3.624
Authors: Jesse W Delaney; Ruxandra Pinto; Jennifer Long; François Lamontagne; Neill K Adhikari; Anand Kumar; John C Marshall; Deborah J Cook; Philippe Jouvet; Niall D Ferguson; Donald Griesdale; Lisa D Burry; Karen E A Burns; Jamie Hutchison; Sangeeta Mehta; Kusum Menon; Robert A Fowler Journal: Crit Care Date: 2016-03-30 Impact factor: 9.097